Depressive symptoms and risk of dementia: The framingham heart study

Neurology

Volumn 75, Issue 1, 2010, Pages 35-41

  Saczynski, J S ^a   Beiser, A ^b,c   Seshadri, S ^c   Auerbach, S ^c   Wolf, P A ^c   Au, R ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E4; HOMOCYSTEINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; EDUCATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COHORT STUDIES; CORONARY DISEASE; DEMENTIA; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS;

EID: 77954649554     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181e62138     Document Type: Article

References (39)

1. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006;63:273-279.
2. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust NZ J Psychiatry 2001;35: 776-781.
3. Jorm AF, van Duijn CM, Chandra V, et al. Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies: EURODEM Risk Factors Research Group. Int J Epidemiol 1991;20:S43-S47.
4. Speck CE, Kukull WA, Brenner DE, et al. History of depression as a risk factor for Alzheimer's disease. Epidemiology 1995;6:366-369.
5. Green RC, Cupples LA, Kurz A, et al. Depression as a risk factor for Alzheimer disease: the MIRAGE study. Arch Neurol 2003;60:753-759.
6. Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002;59:364-370.
7. Devanand DP, Sano M, Tang M-X, et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996;53:175-182.
8. Berger AK, Fratiglioni L, Forsell Y, Winblad B, Backman L. The occurrence of depressive symptoms in the preclini-cal phase of AD: a population-based study. Neurology 1999;53:1998-2002.
9. Chen P, Ganguli M, Mulsant BH, DeKosky ST. The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry 1999;56:261-266.
10. Becker JT, Chang YF, Lopez OL, et al. Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry 2009;17:653-663.
11. Henderson AS, Korten AE, Jacomb PA, et al. The course of depression in the elderly: a longitudinal community-based study in Australia. Psychol Med 1997;27:119-129.
12. Geerlings MI, Bouter LM, Schoevers R, et al. Depression and risk of cognitive decline and Alzheimer's disease: results of two prospective community-based studies in the Netherlands. Br J Psychiatry 2000;176:568-575.
13. Fuhrer R, Dufouil C, Dartigues J. Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study. J Am Geriatr Soc 2003;51:1055-1063.
14. Forno G, Palermo M, Donohue J, Karagiozis H, Zonder-man A, Kawas C. Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol 2005;57:381-387.
15. Farmer ME, White LR, Kittner SJ, et al. Neuropsychological test performance in Framingham: a descriptive study. Psychol Rep 1987;60:1023-1040.
16. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Methods 1977;1:385-401.
17. Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006;37:345-350.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
19. Berg L. Clinical Dementia Rating (CDR). Psychopharma-col Bull 1988;24:637-639.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34: 939-944.
21. ArakiA, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
22. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocystinemia in an elderly population. JAMA 1993; 270:2693-2698.
23. OrdovasJM, Litwack-Klein L, Wilson PW, SchaeferMM, Schaefer EJ. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 andapoE5 isoforms. J Lipid Res 1987;28:371-380.
24. Welty FK, Lahoz C, Tucker KL, Ordovas JM, Wilson PWF, Schaefer EJ. Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the Framingham offspring population. Arterioscler Thromb Vasc Biol 1998;18:1745-1751.
25. Irie F, Masaki KH, Petrovitch H, et al. Apolipoprotein E e4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study. Arch Gen Psychiatry 2008;65:906-912.
26. Dal Forno G, Palermo MT, Donohue JE, Karagiozis H, Zonderman AB, Kawas CH. Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol 2005;57:381-387.
27. Leonard BE. Inflammation, depression and dementia: are they connected? Neurochem Res 2007;32:1749-1756.
28. Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol 2004;61:668-672.
29. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002;90:1279-1283.
30. Zuccato C, Cattaneo E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 2009;5:311-322.
31. Tsai S-J. Brain-derived neurotrophic factor: a bridge between major depression and Alzheimer's disease? Med Hy-poth 2003;61:110-113.
32. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Sil-bersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997;54:915-922.
33. Steffens DC, Helms MJ, Krishnan KR, Burke GL. Cere-brovascular disease and depression symptoms in the Cardiovascular Health Study. Stroke 1999;30:2159-2166.
34. Tiemeier H, Breteler MM, van Popele NM, Hofman A, Witteman JC. Late-life depression is associated with arterial stiffness: a population-based study. J Am Geriatr Soc 2003;51:1105-1110.
35. Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MMB. Vitamin B12, folate, and homocys-teine in depression: the Rotterdam Study. Am J Psychiatry 2002;159:2099-2101.
36. Penninx BWJH, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP. Vitamin B12 deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry 2000;157:715-721.
37. van Gool CH, Kempen GI, Penninx BW, Deeg DJ, Beek-man AT, van Eijk JT. Relationship between changes in depressive symptoms and unhealthy lifestyles in late middle aged and older persons: results from the Longitudinal Aging Study Amsterdam. Age Ageing 2003;32:81-87.
38. Lampinen P, Heikkinen R-L, Ruoppila I. Changes in intensity of physical exercise as predictors of depressive symptoms among older adults: an eight-year follow-up. Prev Med 2000;30:371-380.
39. Saczynski JS, Pfeifer LA, Masaki K, et al. The effect of social engagement on incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol 2006;163:433-440.